133 related articles for article (PubMed ID: 7259296)
1. Enhancement of granulocyte chemotaxis in Behcet's disease.
Djawari D; Hornstein OP; Schötz J
Arch Dermatol Res; 1981; 270(1):81-8. PubMed ID: 7259296
[TBL] [Abstract][Full Text] [Related]
2. Skin window examination according to Rebuck and cutaneous pathergy tests in patients with Behcet's disease.
Djawari D; Hornstein OP; Luckner L
Dermatologica; 1985; 170(6):265-70. PubMed ID: 3894082
[TBL] [Abstract][Full Text] [Related]
3. [Cellular immune status and microphage function in Behçet's disease].
Djawari D; Hornstein OP
Z Hautkr; 1980 Mar; 55(5):271-92. PubMed ID: 6996366
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.
Neves FS; Carrasco S; Goldenstein-Schainberg C; Gonçalves CR; de Mello SB
Clin Rheumatol; 2009 Dec; 28(12):1403-10. PubMed ID: 19701803
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of hyperchemotaxis in Behçet's disease.
Takeuchi A; Kobayashi K; Mori M; Mizushima Y
J Rheumatol; 1981; 8(1):40-4. PubMed ID: 7218257
[TBL] [Abstract][Full Text] [Related]
6. [The "unspecific" immune state in skin diseases with special reference to microphage functions].
Djawari D; Simon M
Z Hautkr; 1985 Apr; 60(8):628, 633-4, 637-8 passim. PubMed ID: 3890390
[TBL] [Abstract][Full Text] [Related]
7. Behçet's syndrome: pathogenesis, diagnosis, and treatment.
Jorizzo JL
Cutis; 1983 Nov; 32(5):441-5, 448. PubMed ID: 6653169
[TBL] [Abstract][Full Text] [Related]
8. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G
Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603
[TBL] [Abstract][Full Text] [Related]
9. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
10. [HLA typing in patients of German origin with recurrent benign aphthosis and Behçet's disease].
Djawari D; Lang B; Hornstein OP
Z Hautkr; 1984 Aug; 59(15):1005-9. PubMed ID: 6485449
[TBL] [Abstract][Full Text] [Related]
11. Non-phagocytic beta-glucuronidase release in Behçet's disease.
Takeuchi A; Kobayashi K; Mori M; Hashimoto A
Clin Exp Rheumatol; 1986; 4(1):3-7. PubMed ID: 3698358
[TBL] [Abstract][Full Text] [Related]
12. Complex aphthosis: a forme fruste of Behçet's syndrome?
Jorizzo JL; Taylor RS; Schmalstieg FC; Solomon AR; Daniels JC; Rudloff HE; Cavallo T
J Am Acad Dermatol; 1985 Jul; 13(1):80-4. PubMed ID: 4031155
[TBL] [Abstract][Full Text] [Related]
13. Possible mechanisms of neutrophil activation in Behçet's disease.
Neves FS; Spiller F
Int Immunopharmacol; 2013 Dec; 17(4):1206-10. PubMed ID: 23973446
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
15. Distinct transcriptional profile of blood mononuclear cells in Behçet's disease: insights into the central role of neutrophil chemotaxis.
Verrou KM; Vlachogiannis NI; Ampatziadis-Michailidis G; Moulos P; Pavlopoulos GA; Hatzis P; Kollias G; Sfikakis PP
Rheumatology (Oxford); 2021 Oct; 60(10):4910-4919. PubMed ID: 33493315
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil chemotaxis in Behçet's syndrome.
Tüzün B; Tüzün Y; Yurdakul S; Hamuryudan V; Yazici H; Ozyazgan Y
Ann Rheum Dis; 1999 Oct; 58(10):658. PubMed ID: 10577375
[No Abstract] [Full Text] [Related]
17. Neutrophils contribute to vasculitis by increased release of neutrophil extracellular traps in Behçet's disease.
Safi R; Kallas R; Bardawil T; Mehanna CJ; Abbas O; Hamam R; Uthman I; Kibbi AG; Nassar D
J Dermatol Sci; 2018 Nov; 92(2):143-150. PubMed ID: 30237006
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 expression in skin pathergy reaction of Behçet's disease.
Sullu Y; Senturk N; Yildiz L; Sullu YD; Turanli AY
Dermatology; 2001; 202(2):90-3. PubMed ID: 11306827
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic proline-rich polypeptide is a regulator of oxidative burst in human neutrophils and monocytes.
Davtyan TK; Manukyan HA; Mkrtchyan NR; Avetisyan SA; Galoyan AA
Neuroimmunomodulation; 2005; 12(5):270-84. PubMed ID: 16166806
[TBL] [Abstract][Full Text] [Related]
20. Polymorphonuclear function in Behçet's syndrome.
Fordham JN; Davies PG; Kirk A; Currey HL
Ann Rheum Dis; 1982 Aug; 41(4):421-5. PubMed ID: 7051990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
